Increased morbidity in combined abdominal sacrocolpopexy and abdominoplasty procedures.

International urogynecology journal 2013 Vol.24(3) p. 385-91

Meriwether KV, Antosh DD, Knoepp LR, Chen CC, Mete M, Gutman RE

관련 도메인

Abstract

[INTRODUCTION AND HYPOTHESIS] This study was performed to determine whether abdominoplasty combined with abdominal sacrocolpopexy (ASC + A) increases perioperative morbidity compared with ASC alone. We hypothesized that patients undergoing combined procedures would have increased complications.

[METHODS] This was a multicenter, retrospective cohort study of all women undergoing ASC + A from 2002 to 2010 at Washington Hospital Center and Johns Hopkins University. We selected two women undergoing ASC alone for comparison with each ASC + A patient. Baseline demographics, surgical data, length of hospitalization, and perioperative complications were recorded. The primary outcome was any major complication within 6 weeks of surgery, including intraoperative complications, pulmonary embolism (PE), deep venous thrombosis (DVT), cardiac compromise, intensive care unit (ICU) admission, reoperation, and readmission. Surgical data and minor complications were also compared.

[RESULTS] Twenty-six ASC + A patients and 52 ASC patients were identified. There were no significant differences in baseline characteristics between groups. Patients with ASC + A had longer operating times (337 vs 261 min, p < 0.01), more intravenous fluid administration intraoperatively (4,665 vs 3181 ml, p < 0.01), and longer hospital stays (3.7 vs 2.7 days, p < 0.01). Major complications occurred in 23 % of the ASC + A group compared with 12 % of the ASC group (p = 0.20). The ASC + A group had greater declines in hematocrit levels and higher rates of PE, ICU admission, and blood transfusion, all of which were statistically significant.

[CONCLUSIONS] ASC + A increases length of stay and perioperative complications, such as PE, ICU admission, and blood transfusion, compared with ASC alone. Surgeons should consider recommending interval abdominoplasty due to increased morbidity risk with a combined procedure.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 abdominoplasty 복부성형술 dict 3
해부 ASC scispacy 1
해부 pulmonary scispacy 1
해부 cardiac scispacy 1
해부 intravenous fluid administration intraoperatively (4,665 vs 3181 ml scispacy 1
해부 hematocrit scispacy 1
해부 blood scispacy 1
약물 [INTRODUCTION AND HYPOTHESIS] scispacy 1
약물 [CONCLUSIONS] ASC scispacy 1
질환 pulmonary embolism C0034065
Pulmonary Embolism
scispacy 1
질환 venous thrombosis C0042487
Venous Thrombosis
scispacy 1
질환 DVT → deep venous thrombosis C0149871
Deep Vein Thrombosis
scispacy 1
기타 ASC + scispacy 1
기타 patients scispacy 1
기타 women scispacy 1
기타 ASC scispacy 1
기타 venous scispacy 1

MeSH Terms

Abdomen; Abdominoplasty; Adult; Aged; Cohort Studies; Colposcopy; Female; Hematocrit; Humans; Incidence; Length of Stay; Middle Aged; Operative Time; Physician-Patient Relations; Postoperative Complications; Retrospective Studies; Risk Factors

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문